Cardinal Health Extends Distribution Agreement with CVS Health Through 2032
News related to:Cardinal Health · 2 min read
DUBLIN, Ohio, Oct. 1, 2026 /CourierPR/ -- Cardinal Health has entered into a binding Letter of Intent to extend its existing distribution agreement with CVS Health through June 30, 2032. This agreement ensures the continuation of Cardinal Health's current scope of distribution services to CVS Health, reflecting the long-standing partnership between the two companies.
The agreement comes with a reaffirmation of Cardinal Health's fiscal year 2027 non-GAAP EPS guidance of 13% to 15% growth, projected to range between $12.40 and $12.60. Additionally, the company has reaffirmed its long-term non-GAAP EPS growth rate guidance of 12% to 14%. Further updates on these projections may be provided during the company's upcoming first quarter earnings call on November 5, 2026.
Cardinal Health is a distributor of pharmaceuticals and specialty products, a global manufacturer and distributor of medical and laboratory products, a supplier of home-health and direct-to-patient products and services, an operator of nuclear pharmacies and manufacturing facilities, and a provider of performance and data solutions. The company's customer-centric focus drives continuous improvement and leads to innovative solutions that improve people's lives every day.
The extension of the distribution agreement with CVS Health underscores the importance of Cardinal Health's role in the pharmaceutical and healthcare industries. The agreement is expected to strengthen the relationship between the two companies and ensure a continued supply of essential products to CVS Health's network of pharmacies and healthcare providers.
Cardinal Health's reaffirmation of its financial guidance indicates confidence in its business model and operational capabilities. The company's commitment to maintaining a steady growth trajectory is a testament to its strategic focus on expanding its distribution network and enhancing its service offerings.
As the agreement extends through 2032, it is expected to provide stability and predictability for both Cardinal Health and CVS Health, allowing both companies to plan for the future with confidence. The partnership is seen as a critical component of Cardinal Health's strategy to maintain its market position and continue to serve the evolving needs of the healthcare industry.
The extension of the agreement with CVS Health is part of Cardinal Health's broader strategy to strengthen its relationships with key partners and expand its market presence. The company's focus on innovation and customer service is expected to drive continued growth and success in the coming years.